In this study, we show that CD34+CD90+HSC fraction of HSPCs have reduced CD4/CCR5 receptors and increased antiviral restriction factors to limit the HIV-1 infection and demonstrate that they are the potential target cells for CCR5 gene editing. This evidence concerns the gene THY1 and HIV-1 infection.